What Are the Effects of Tobacco Smoking on the Central Nervous System?
Smoking tobacco has powerful effects on the central nervous system. Cigarettes act as a central nervous system stimulant, affecting the neurotransmitters serotonin, dopamine, norepinephrine, acetylcholine, GABA and others. The most significant ingredient in tobacco smoke is nicotine, the component that causes addiction. There are also over 600 documented cigarette additives in commercial tobacco, and 100 of these have been found to have pharmacological effects on the body, especially the central nervous system.
Anxiety
Smoking cigarettes affects the neurotransmitters associated with anxiety and the state of wellness. Smokers have significantly higher rates of clinical anxiety compared to non-smokers. This may be explained through tobacco's effect on GABA, the neurotransmitter most responsible for the state of wellness and a lack of anxiety. In the September 2007 issue of "BMC Neuroscience," Dr. Tamaki Hayase found that nicotine significantly increased anxiety related behaviors and symptoms, even 2 hours after the last exposure. In addition, in the June 2007 issue of the "Journal of Applied Biobehavioral Research," Dr. Janet Audrain and associates found that anxiety was significantly correlated to nicotine intake. The largest co-factors in smoking-related anxiety were level of addiction, when people smoked because they were having a bad day, smoked in order to wake up, and smokers who had low levels of self-esteem.
- Smoking cigarettes affects the neurotransmitters associated with anxiety and the state of wellness.
- In the September 2007 issue of "BMC Neuroscience," Dr. Tamaki Hayase found that nicotine significantly increased anxiety related behaviors and symptoms, even 2 hours after the last exposure.
Depression
Foods That Trigger Depression
Learn More
Smoking is also strongly related to depression. Nicotine and other tobacco additives have a direct negative impact on dopamine and serotonin, two neurotransmitters associated with depression and mental health. Some smokers may use cigarettes to feel better, while nicotine withdrawal may itself cause the depression in the first place. In the January 2008 issue of "Nicotine & Tobacco Research," Dr. Michael Lyons and associates found that major depression was significantly associated with current daily smoking as well as nicotine withdrawal. Some of the accompanying depressive symptoms were nervousness, restlessness and difficulty concentrating.
- Smoking is also strongly related to depression.
- In the January 2008 issue of "Nicotine & Tobacco Research," Dr. Michael Lyons and associates found that major depression was significantly associated with current daily smoking as well as nicotine withdrawal.
Cognition
Smoking cigarettes can also have a serious negative impact on cognitive abilities, especially with long-term smokers. Nicotine directly affects the neurotransmitters associated with learning, memory and cognition. The hundreds of additives in cigarettes also have a negative effect of cognition. Long term smokers are at a particular risk for developing dementia as they get older. In the August 2007 issue of "Neuropsychology Review," Dr. Gary Swan and associates found that smoking was significantly associated with brain matter degeneration and cellular death, cognitive decline over repeated measures and dementia. In the report, they also found that mothers who smoke put their child at an increased risk for neuro-developmental deficits.
- Smoking cigarettes can also have a serious negative impact on cognitive abilities, especially with long-term smokers.
- In the report, they also found that mothers who smoke put their child at an increased risk for neuro-developmental deficits.
Related Articles
References
- "American Journal of Public Health": Pharmacological and Chemical Effects of Cigarette Additives
- BioMed Central: Chronologically Overlapping Occurrences of Nicotine-Induced Anxiety- and Depression-Related Behavioral Symptoms: Effects of Anxiolytic and Cannabinoid Drugs
- "Journal of Applied Biobehavioral Research"; The Role of Trait Anxiety in Nicotine Dependence; Janet Audrain; June 2007
- "Nicotine & Tobacco Research"; A Twin Study of Smoking, Nicotine Dependence, and Major Depression in Men; Michal Lyons; January 2008
- "Neuropsychology Review": The Effects of Tobacco Smoke and Nicotine on Cognition and the Brain
- Centers for Disease Control and Prevention. Data and statistics: Smoking & tobacco use. Updated August 25, 2020.
- National Institute on Drug Abuse for Teens. Why is nicotine so addictive?. Updated February 4, 2019.
- World Health Organization. Tobacco.
- National Institute on Drug Abuse. Is nicotine addictive?.
- Federal Register. Nicotine; Product cancellation order.
- European Commission. Neonicotinoids.
- U.S. Environmental Protection Agency. EPA releases proposed interim decisions for neonicotinoids. January 30, 2020.
- U.S. Food and Drug Administration. Selling tobacco products in retail stores. Updated June 3, 2020.
- Holbrook B. The effects of nicotine on human fetal development. Birth Defects Research Part C: Embryo Today: Reviews. 2016;108(2):181-192. doi:10.1002/bdrc.21128
- D'Alessandro A, Boeckelmann I, Hammwhöner M, Goette A. Nicotine, cigarette smoking and cardiac arrhythmia: an overview. Eur J Prev Cardiol. 2011;19(3):297-305. doi:10.1177/1741826711411738
- Harvard Health. Nicotine: It may have a good side. March, 2014.
- Barreto GE, Iarkov A, Moran VE. Beneficial effects of nicotine, cotinine and its metabolites as potential agents for Parkinson's disease. Front Aging Neurosci. 2015;6:340. doi:10.3389/fnagi.2014.00340
- Lakhan SE, Kirchgessner A. Anti-inflammatory effects of nicotine in obesity and ulcerative colitis. J Transl Med. 2011;9,129. doi:10.1186/1479-5876-9-129
- Chaturvedi P, Mishra A, Datta S, Sinukumar S, Joshi P, Garg A. Harmful effects of nicotine. Indian Journal of Medical and Paediatric Oncology. 2015;36(1):24. doi:10.4103/0971-5851.151771
- PubChem. Nicotine.
Resources
Writer Bio
Boyd Bergeson has been writing since 2000 and has contributed to published research with the National Institute of Health and The Indian Health Board. Bergeson is currently a mental health professional and has worked as a university instructor, senior medical research assistant, textbook editor, and bicycle shop owner. He has a Master of Science in sociology from Portland State University.